Background: We investigated the relationship between serum total carbon dioxide (CO 2 ) and bicarbonate ion (HCO 3 -) concentrations in pre-dialysis chronic kidney disease (CKD) patients and devised a formula for predicting low bicarbonate (HCO 3 -< 24 mmol/L) and high bicarbonate (HCO 3 -≥ 24 mmol/L) using clinical parameters. Methods: In total, 305 samples of venous blood collected from 207 pre-dialysis patients assessed by CKD stage (G1 + G2, 46; G3, 50; G4, 51; G5, 60) were investigated. The relationship between serum total CO 2 and HCO 3 -concentrations was analyzed using Pearson's correlation coefficient. An approximation formula was developed using clinical parameters correlated independently with HCO 3 -concentration. Diagnostic accuracy of serum total CO 2 and the approximation formula was evaluated by receiver operating characteristic curve analysis and a 2 × 2 table. Results: Serum total CO 2 correlated strongly with HCO 3 -concentration (r = 0.91; P < 0.001). The following approximation formula was obtained by a multiple linear regression analysis: HCO 3 -(mmol/L) = total CO 2 -0.5 × albumin -0.1 × chloride -0.01 × (estimated glomerular filtration rate + blood glucose) + 15. The areas under the curves of serum total CO 2 and the approximation formula for detection of low bicarbonate and high bicarbonate were 0.981, 0.996, 0.993, and 1.000, respectively. This formula had superior diagnostic accuracy compared with that of serum total CO 2 (86.6% vs. 81.3%). Conclusion: Serum total CO 2 correlated strongly with HCO 3 -concentration in pre-dialysis CKD patients. An approximation formula including serum total CO 2 showed superior diagnostic accuracy for low and high bicarbonate compared with serum total CO 2 .
Introduction
Metabolic acidosis is a common complication of chronic kidney disease (CKD) and can lead to bone mineral loss, protein wasting, progression of renal dysfunction, and higher mortality risk [1] [2] [3] . Therefore, early detection and accurate diagnosis of metabolic acidosis are important to prevent CKD progression and increased risk of mortality.
In Japan, blood-gas analyzers are available in most hospitals. Therefore, clinical practice guidelines for CKD recommend measurement of bicarbonate ions (HCO 3 -) using samples of arterial/venous blood gases for assessment of metabolic acidosis in pre-dialysis CKD patients [4] . However, for these blood-gas analyses, a specific measurement device and syringe are required in addition to the blood samples used for biochemical analyses [5] . Serum total carbon-dioxide concentration (serum total CO 2 ) can be measured readily, along with creatinine, urea, and electrolytes, using a biochemical analyzer in clinical settings [6] . Furthermore, values based on this measurement have been shown to be correlated strongly with HCO 3 -concentration in patients without renal impairment [7] . However, few studies have examined the relationship between serum total CO 2 and HCO 3 -concentration in patients with renal impairment. Therefore, we analyzed the relationship between these two parameters in CKD patients who were not undergoing renal replacement therapy. Furthermore, we developed a new formula for approximation of HCO 3 -concentration using clinical parameters that included serum total CO 2 and evaluated the diagnostic accuracy of the approximated values derived from this new formula.
Methods

Ethical approval of the study protocol
This study was carried out in accordance with the ethical principles contained within the Declaration of Helsinki. The study protocol was approved by the Ethics Committee of Saitama Medical Center, Jichi Medical University (No. S17-052; Saitama, Japan). The requirement of informed consent was waived, and an opt-out method was used due to the retrospective design of the study.
Inclusion and exclusion criteria
Inclusion criteria were (i) age > 20 years; (ii) stable outpatient with CKD stage G1 to 5; and (iii) simultaneous measurement of serum total CO 2 and HCO 3 -concentration. Exclusion criteria were patients (i) undergoing dialysis therapy and (ii) who had undergone renal transplantation.
Study design
This was a single-center, retrospective, cross-sectional study. We analyzed patient data obtained from medical records from the Division of Nephrology, Saitama Medical Center, between April 2016 and March 2018. Laboratory data of blood tests and blood-gas tests obtained simultaneously were used for analyses.
The relationship between serum total CO 2 and HCO 3 -concentration was analyzed using Pearson's correlation coefficient. An approximation formula was developed by multiple linear regression analysis with independent factors correlated with HCO 3 -concentration. The relationship between HCO 3 -concentration approximated by our formula and actual HCO 3 -concentration was analyzed using Pearson's correlation coefficient. The diagnostic accuracy of serum total CO 2 and approximated HCO 3 -concentration for low and high bicarbonate levels was analyzed using receiver operating characteristic (ROC) curve analysis and a 2 × 2 table.
Laboratory methods
Blood and urinary parameters were determined by the Department of Clinical Laboratory, Saitama Medical Center. Samples of venous blood were collected in ethylenediamine tetraacetic acid (EDTA)-containing tubes from the brachial vein and centrifuged within 15 minutes to obtain serum. Serum total CO 2 was measured within 15 minutes after centrifugation using an automated biochemical analyzer (JCA-BM6070; JEOL, Tokyo, Japan), as were the biochemical parameters hemoglobin, total protein, serum albumin, blood urea nitrogen, serum creatinine, sodium, potassium, chloride, calcium, phosphate, magnesium, and glucose. Serum total CO 2 was determined by an enzymatic method using a commercial kit (Toyobo, Osaka, Japan).
Samples of venous blood for gas analyses were collected in a heparinized blood-gas syringe from the brachial vein simultaneously with samples for other blood tests. These samples were analyzed within 10 minutes to obtain values for pH and partial pressure of carbon dioxide (pCO 2 ). Blood pH and pCO 2 were measured using a blood-gas analyzer (Rapidlab-1265; Siemens Healthcare Diagnostics, Tarrytown, NY, USA 
Results
Patient characteristics
The characteristics of patients and their medications were categorized by CKD stage (G1 + G2, G3, G4, G5) ( Table 1) . A total of 305 blood samples from 207 patients Data are presented as number only, mean ± standard deviation, or number (%).
www.krcp-ksn.org (139 males, 68 females; mean age, 64.7 ± 16.1 years) was obtained. The number of patients for each CKD stage was 46 for G1 + G2, 50 for G3, 51 for G4, and 60 for G5. There were significant differences in age as well as use of corticosteroid, β-blocker, loop diuretic, sodium bicarbonate, potassium binder, phosphate binder, or inhibitor of the renin-angiotensin system (RAS) among groups categorized by CKD stage. Age was significantly lower in patients with CKD stage G1 + G2 than those with CKD stage G3, G4, or G5 (P < 0.001 for all).
The proportions of patients using a β-blocker (P < 0.005, G1 + G2 vs. G4 and G5), RAS inhibitor (P < 0.05, G1 + G2 vs. G4 and G5), loop diuretic (P < 0.001, G1 + G2 vs. G3, G4, and G5), thiazide diuretic (P < 0.005, G3 vs. G5), sodium bicarbonate (P < 0.05, G5 vs. G1 + G2 and G3), potassium binder (P < 0.01, G1 + G2 vs. G5), or phosphate binder (P < 0.05, G5 vs. G1 + G2 and G3) increased significantly with CKD stage. The percentage of patients using a corticosteroid decreased with CKD stage (P < 0.05, G1 + G2 vs. G5).
Correlation between serum total CO 2 and HCO 3 -concentration Fig. 1 shows the correlation between serum total CO 2 and HCO 3 -concentration in each group categorized by CKD stage. Serum total CO 2 was correlated with HCO 3 -concentration significantly and substantially in all patients (r = 0.91; P < 0.001), patients with CKD stage G1 + G2 (r = 0.88; P < 0.001), patients with CKD stage G3 (r = 0.84; P < 0.001), patients with CKD stage G4 (r = 0.89; P < 0.001), and patients with CKD stage G5 (r = 0.93; P < 0.001). 
Formula for approximation of HCO 3 -concentration
A simple linear regression analysis showed that HCO 3 -concentration was significantly negatively correlated with age, blood urea nitrogen, potassium, chloride, phosphate, blood glucose, and use of an RAS inhibitor, sodium bicarbonate, potassium binder, or phosphate binder. The HCO 3 -concentration showed significant positive correlations with serum albumin, hemoglobin, eGFR, total calcium, serum total CO 2 , and use of a corticosteroid or aldosterone receptor antagonist. We performed a multivariate linear regression analysis using variables that showed a significant correlation with HCO 3 -concentration in the simple linear regression analysis ( Table 2 ). The multiple linear regression analysis revealed that serum albumin (P = 0.006), eGFR (P = 0.047), chloride (P < 0.001), blood glucose (P = 0.004), and serum total CO 2 (P < 0.001) were independently correlated with HCO 3 -concentration.
An approximated HCO 3 -formula based on serum total CO 2 was developed using variables that showed a significant correlation with HCO 3 - 
Discussion
We assessed the relationship between serum total CO 2 and HCO 3 -concentration in CKD patients who were not undergoing renal replacement therapy. This assessment enabled development of an approximation formula for prediction of low bicarbonate and high bicarbonate using clinical parameters involving serum total CO 2 . Serum total CO 2 is the total concentration of all forms of CO 2 in a serum sample: HCO 3 -, carbonate, and dissolved CO 2 . In general, serum total CO 2 value is approximately www.krcp-ksn.org equivalent to the HCO 3 -concentration because most of the CO 2 in blood exists as HCO 3 - [6] . Furthermore, serum total CO 2 was shown to have a substantial correlation with HCO 3 -concentration by Kumar and Karon [7] . However, a discrepancy between serum total CO 2 and HCO 3 -concentration caused by the influence of temperature and acidity [11] is occasionally observed in patients without renal impairment [12] . In the present study, serum albumin, eGFR, chloride, and blood glucose, in addition to serum total CO 2 , were independently associated with HCO 3 -concentration in serum.
Increased serum albumin has been reported to be associated with metabolic acidosis in pre-dialysis CKD patients [13] , and this phenomenon can be explained, at least in part, by the weak acidity of albumin [14] . These findings are consistent with our result showing a negative correlation between the concentrations of albumin and HCO 3 -in serum. Furthermore, the HCO 3 -concentration in serum decreases with progression of CKD stage [13] , and this reduction has been suggested to be due to the inability of the kidney to synthesize ammonia, regenerate HCO 3 -, and excrete hydrogen ions (H + ) [15] .
Therefore, HCO 3 -concentration was expected to have a positive correlation with eGFR. However, in the present study, HCO 3 -concentration was negatively correlated with GFR. This difference between our result and those of published reports may be explained by the increase in the ratio of use of diuretics and sodium bicarbonate with progression of CKD stage because such use leads to an increase in HCO 3 -concentration in serum [13, 16] . Loop diuretics and thiazide diuretics inhibit the Na + -K + -2Cl -cotransporter and Na + -Cl -cotransporter, respectively, and increase sodium delivery to distal tubular segments. The delivered sodium is reabsorbed at cortical collecting ducts due to, at least in part, the increase of serum aldosterone induced by diuretic-associated reduction of intravascular fluids [17] . Furthermore, an increase in serum aldosterone associated with diuretic use stimulates H + -ATPase activity at cortical collecting ducts [18] , which leads to an increase in HCO 3 -concentration in serum. An increase in serum aldosterone also stimulates potassium excretion at cortical collecting ducts, which leads to a decrease in serum potassium concentration [19] . A decreased serum potassium concentration may increase renal production of ammonia and excretion of ammonium ions, which result in an increase in HCO 3 -concentration in serum [20] . In addition, sodium bicarbonate is administered frequently in CKD patients with metabolic acidosis. Therefore, use of diuretics and sodium bicarbonate may reflect the inverse relationship between changes in eGFR and HCO 3 -concentration in serum noted in our study. However, further studies in a much larger cohort are needed to confirm the relationship between these factors. Hyperchloremic metabolic acidosis is observed in 30% to 50% of patients with chronic renal failure [21] . The chloride concentration in serum has been reported to increase as HCO 3 -concentration in serum decreases [22] .
We documented a negative correlation between chloride and HCO 3 -concentrations in serum with progression of CKD stage, a finding that is compatible with that of Widmer et al [22] . Blood glucose was negatively correlated with HCO 3 -concentration in serum in the present study.
Uremia inhibits insulin secretion as well as insulin sensitivity [23] , which leads to an increase in blood glucose concentration with metabolic acidosis via reduction in Na + /H + exchanger activity [24] . Glucose appears in urine if the blood glucose concentration exceeds the renal threshold of 170 to 200 mg/dL [25] . Increased urinary glucose has been shown to inhibit H+ excretion through proximal renal tubules [26] and activates the sodiumglucose-coupled transporter, which inhibits the Na + -H + exchanger via competition for sodium influx. The subsequent decreased H + excretion leads to metabolic acidosis with a reduction of HCO 3 -concentration in plasma [27] .
Therefore, our findings may be explained by data reported previously. Measurement of serum total CO 2 has two main advantages compared with blood-gas analyses. First, the cost of a blood-gas syringe can be saved, and the amount of blood collected is reduced. Second, serum total CO 2 can be used to predict metabolic acidosis and metabolic alkalosis without use of a blood-gas analyzer. Therefore, measurement of serum total CO 2 would alleviate some of the burden on patients and laboratory staff. In addition, the approximated HCO 3 -concentration derived from clinical parameters, including serum total CO 2 , could have been useful for predicting disturbances of acid-base metabolism in the present study. Our study had four main limitations. First, this was a single-center, retrospective, observational study and may have been subject to bias in patient selection. Second, the study cohort was small, which limits the generalizability of our findings. Third, several baseline characteristics, including age and medication use, were significantly different among groups categorized by CKD stage. Fourth, we used venous blood samples for analyses. The results might have been different if samples of arterial blood had been used. However, pH and HCO 3 -have been reported to show sufficient agreement between arterial and venous blood-gas analysis [28] . Therefore, further prospective, large-scale, multicenter studies with arterial blood samples for gas analysis are required to confirm our findings.
In conclusion, serum total CO 2 was substantially correlated with HCO 3 -concentration in the serum of pre-dialysis CKD patients. An approximation formula including serum total CO 2 showed superior diagnostic accuracy for low and high bicarbonate levels compared with serum total CO 2 .
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